Eli Lilly

Person poised to take a pill

Firms face pressure from shifting demand after weight-loss pills approved

A person injects their abdomen with a weight loss pen

Mounjaro sales double this year as obesity drug boom prevails, says maker

Novo Nordisk shares plunge on outlook warning as Mounjaro rival races ahead

Novo Nordisk cuts sales and profits guidance amid obesity drug competition

Almost 2.5 million purchased weight-loss jabs in July, estimates suggest

Pfizer ramps up obesity treatments push with 4.9 billion dollar deal for Metsera

Ozempic maker to slash 9,000 jobs globally as competition intensifies

Weight-loss jabs: Wes Streeting pledges to do more to stop people being ‘priced ...

Cost of Mounjaro to be discounted in UK pharmacies

Wegovy sales spike after maker of rival Mounjaro ramps up UK price

Christopher Biggins will also appear at the Hippodrome as King Richard (Maja Smiejkowska/PA)

Christopher Biggins reveals he is using weight loss jabs after knee surgery

Government partners with Mounjaro maker to tackle obesity

High demand expected for new daily weight loss pill

Alzheimer’s drug rejected for widespread use by NHS spending watchdog

Donanemab – what we know about the latest Alzheimer’s drug

Decision expected on new Alzheimer’s treatment

Global alert issued over fake weight loss and diabetes drugs
The World Health Organisation and US drug manufacturer Eli Lilly have issued warnings.
Editorial Team

Diabetes drug recommended to treat obesity on the NHS

Being obese for a decade ‘puts people at greater risk of heart attack or stroke’

Local news you can trust

© 2026 Iconic Media Group Ltd. All rights reserved.Terms and Conditions Privacy notice